06:59:00·51d

Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.

Health Care

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Open live feed

Companies

QTTB
Q32 Bio Inc.
Health Care

Recent analyst ratings

Feb 25UpdateH.C. Wainwright$13.00
Feb 11UpdateBMO Capital Markets$3.00
Feb 11UpdatePiper Sandler$4.00
Dec 11UpdateGuggenheim-
Dec 11UpdateWells Fargo$16.00
Dec 11UpdateRaymond James$22.00

SEC1h
SEC Form DEFA14A filed by Q32 Bio Inc.
SEC1h
SEC Form DEF 14A filed by Q32 Bio Inc.
SEC5d
SEC Form 8-K filed by Q32 Bio Inc.
SEC5d
SEC Form 424B5 filed by Q32 Bio Inc.
PR22d
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference
SEC33d
SEC Form 8-K filed by Q32 Bio Inc.
SEC33d
SEC Form 424B5 filed by Q32 Bio Inc.
INSIDER40d
SEC Form 4 filed by Violette Shelia M.